Simple item record
Title: TNP- 470 as a potential adjuvant Therapy for Cholangiocarcinoma
Authors: KIDOIKHAMMOUAN, Sonexai
Keywords: TNP- 470,Therapy
TNP- 470 ,Cholangiocarcinoma
Issue Date: 28-Jul-2014
Publisher: Dr LEE Jong-Wook Seoul project
Citation: 103p.
Abstract: TNP-470 exerts the effect on the growth in cancer cells and suppression on tumor progression including in vitro and in animal model. However there is dose limiting toxicity due to high dose of TNP-470 encountered with neurotoxic side effect in cancer patients. Therefore, to overcome the side effect, it has been suggested by using as an adjuvant with chemotherapeutic drugs and other adjuvant therapy. Therefore, according to the urgent need in termination of cancers by applying TNP-470, MetAP2 inhibitors in combination with chemotherapeutic drugs would be the effective strategy for the treatment of several cancers including CCA.
Description: Cholangiocarcinoma(CCA) is identified as an invasive and fetal cancer overall worldwide deriving from biliary epithelium cells including intra-hepatic and extra-hepatic biliary tract(Thongprasert et al., 2005) . In addition, CCA is a high infiltrating growth tumor with high metastasis to lymph and blood vessel (Sriamporn et al., 2004). The malignancy of CCA is not commonly clear to diagnose unless it becomes disseminate resulting in the poorly prognosis even there are many experimental evidences indicating biomarkers and related molecules which inhibited by anti-cancer drugs both in vitro and in vivo, but there is no any standard method to treat CCA patient successfully. To date, the efforts of researchers with various methods to prevent the initial incidence of major risk factor such as Opisthorchis viverrini infection (Andoh et al., 2004; Kim et al., 2009; Poomphakwaen et al., 2009). Altogether, many methods targeting to CCA treatment including surgery, radiation, chemotherapy and other palliative treatments are tested to diminish CCA from the worldwide (Czito et al., 2006; Aljiffry et al., 2009; Han et al., 2009), but there is not any an effective method is conformed in clinical trial. Therefore, with the increasing of CCA prevalence and the urgent need of the most effective methods to treat the patients in the worldwide.
URI: http://hdl.handle.net/11267/2230

Files in This Item: Description Size Format
Proposal presentation.pptx10.75 MBMicrosoft Powerpoint XMLView/Open
View Statistics